Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

Novartis lands itself in hot water over questionable deal with Trump's lawyer, while UK MPs demand UK pharma be aligned with EU operations post-...
The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig is the first CGRP inhibitor to...
Amgen has revealed that its PCSK9 inhibitor Repatha (evolocumab) has received approval from the European Commission in a new indication: to reduce...
Ipsen has revealed that it has received approval for the use of Cabometyx for first-line use in patients with advanced renal cell carcinoma.

Features

Samantha O’Shea explains some of the challenges she faces caring for her son, Ethan, who lives with a debilitating but undiagnosed condition.

Appointments

Akari has lost its second CEO in 12 months after David Horn Solomon was accused of misusing the company credit card for personal purchases, it has...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches